SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-067179
Filing Date
2010-03-25
Accepted
2010-03-25 16:38:54
Documents
18
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 2741499
2 CERTIFICATE OF INCORPORATION dex31.htm EX-3.1 234167
3 FORM OF INCENTIVE STOCK OPTION AGREEMENT dex1013.htm EX-10.13 45633
4 FORM OF NONQUALIFIED STOCK OPTION AGREEMENT FOR GRANTS TO EMPLOYEES dex1014.htm EX-10.14 44861
5 FORM OF NONQUALIFIED STOCK OPTION AGREEMENT FOR GRANTS TO DIRECTORS dex1015.htm EX-10.15 40741
6 SEPARATION AGREEMENT AND GENERAL RELEASE dex1030.htm EX-10.30 49135
7 CONSULTING AND CONFIDENTIALITY AGREEMENT dex1031.htm EX-10.31 37458
8 EMPLOYMENT AGREEMENT dex1038.htm EX-10.38 82598
9 AGREEMENT AND RELEASE dex1041.htm EX-10.41 17279
10 FOURTH AMENDMENT TO EMPLOYMENT AND CONFIDENTIAL INFORMATION AGREEMENT dex1042.htm EX-10.42 9060
11 AMENDMENT, DATED JANUARY 8, 2010, TO THE ASSET PURCHASE AGREEMENT dex1048.htm EX-10.48 152015
12 LIST OF SUBSIDIARIES dex21.htm EX-21 4725
13 CONSENT OF KPMG LLP dex231.htm EX-23.1 4193
14 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 9265
15 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 9334
16 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 5237
17 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 5381
18 GRAPHIC g34478g52k08.jpg GRAPHIC 70774
  Complete submission text file 0001193125-10-067179.txt   3591620
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-09601 | Film No.: 10704892
SIC: 2834 Pharmaceutical Preparations